The mark consists of a sequence of right pointing arrows and the word "INGREZZA".
Mark For: INGREZZA® trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of a sequence of right pointing arrows and the word "INGREZZA".
Research | OneLook Acronym Finder |
Serial Number | 88161461 |
Registration Number | 1466751 |
Mark Literal Elements | INGREZZA |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-11-12 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Allison Strickland Ricketts |
Attorney Docket Number | NEUB 1811641 |
Law Office Assigned | M40 |
Employee Name | CRENNAN, KEVIN GERARD |
2018-10-19 | Application Filed |
2019-01-31 | Location: TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED |
2019-01-31 | Status: Live/Pending |
2019-04-08 | Transaction Date |
2019-09-17 | Published |
2019-09-17 | Published for Opposition |
2019-11-12 | Location: INTENT TO USE SECTION |
2021-05-07 | Status: A third request for extension of time to file a Statement of Use has been granted. |
Party: | Neurocrine Biosciences, Inc. |
Address | 12780 El Camino Real San Diego, CALIFORNIA UNITED STATES 92130 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
24.15.10 | Arrows, more than one; More than one arrow |
26.17.12 | Angles (geometric); Chevrons |
241504 | Arrowheads |
241510 | Arrows, more than one; More than one arrow |
261712 | Angles (geometric); Chevrons |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for human use for schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and Tourette syndrome, movement disorders, namely, Myoclonus, Huntington's chorea, Levodopa-induced dyskinesia, tardive dyskinesia, dystonia, and tics
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
DM0000 | The mark consists of a sequence of right pointing arrows and the word "INGREZZA". |
Description | Date | Proceeding Number |
---|---|---|
ASSIGNED TO EXAMINER | 2021-05-24 | 93928 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-05-11 | |
TEAS EXTENSION RECEIVED | 2021-05-07 | |
EXTENSION 3 GRANTED | 2021-05-07 | 98765 |
EXTENSION 3 FILED | 2021-05-07 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-11-04 | |
TEAS EXTENSION RECEIVED | 2020-11-02 | |
EXTENSION 2 GRANTED | 2020-11-02 | 98765 |
EXTENSION 2 FILED | 2020-11-02 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-05-13 | |
TEAS EXTENSION RECEIVED | 2020-05-11 | |
EXTENSION 1 GRANTED | 2020-05-11 | 98765 |
EXTENSION 1 FILED | 2020-05-11 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-11-12 | |
PUBLISHED FOR OPPOSITION | 2019-09-17 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-09-17 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-08-28 | |
ASSIGNED TO LIE | 2019-08-15 | 74221 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-08-07 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-07-31 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-07-30 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-07-30 | 88889 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-05-17 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-05-17 | |
PRIORITY ACTION WRITTEN | 2019-01-31 | 91238 |
PRIORITY ACTION E-MAILED | 2019-01-31 | 6326 |
NOTIFICATION OF PRIORITY ACTION E-MAILED | 2019-01-31 | 6326 |
ASSIGNED TO EXAMINER | 2019-01-24 | 91238 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-11-01 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-10-31 | |
NEW APPLICATION ENTERED IN TRAM | 2018-10-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.